Matilde Otero-Losada

University of Buenos Aires

Dr. Matilde Otero-Losada graduated from the School of Pharmacy and Biochemistry, University of Buenos Aires (UBA), Argentina. She obtained a SciD in Neuropharmacology from the same univeristy and completed a PhD in Psychiatry at Wolverhampton University, England. Her following studies in psychometrics and statistical methods, radioisotopes and radiochemistry, and signal processing and microcomputers, took her to the University of California San Diego (UCSD) for training in human psychophysics. Back to Argentina, she carried on studying smell, taste, and trigeminal perception at the Hospital de Clínicas, UBA. She is devoted to the diagnosis, counseling, support, and treatment of people with olfactory and neurocognitive disorders. Focused on the study of metabolic syndrome, soft drinks, and cardiovascular-renal morbidity for the last ten years, in the last two years she is back to her roots in neuroscience. Dr. Otero-Losada has published more than ninety 90 papers in prestigious, indexed journals and authored several book chapters. She is a senior researcher at the National Research Council (Argentina) and a reviewer and praised editor of books and scientific journals, acknowledged for her stylish writing and editing skills.

1books edited

4chapters authored

Latest work with IntechOpen by Matilde Otero-Losada

Neurological disease affects nearly 25%–30% of the world’s population, exerting enormous financial strain on the healthcare system. Estimated current costs are around $800 annual billion, and this number is expected to increase exponentially as the global population ages. As such, new and alternative neuroprotective strategies are urgently needed. This book examines some of the most promising approaches in neuroprotection as well as discusses current goals and prospects. Organized into three sections, chapters cover such topics as the use of cannabinoids, medicinal plants, and essential oils in Alzheimer’s and Parkinson’s; protein misfolding and the neuroprotective potential of vitamin E in cerebral ischemia; and potential new neurological treatments and their mechanisms of action.

Go to the book